BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35258164)

  • 1. Examining post-donation outcomes in Hispanic/Latinx living kidney donors in the United States: A systematic review.
    Alvarado F; Cervantes CE; Crews DC; Blanck J; Al Ammary F; Ng DK; Purnell TS
    Am J Transplant; 2022 Jul; 22(7):1737-1753. PubMed ID: 35258164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health outcomes among non-Caucasian living kidney donors: knowns and unknowns.
    Lentine KL; Segev DL
    Transpl Int; 2013 Sep; 26(9):853-64. PubMed ID: 23531054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first increase in live kidney donation in the United States in 15 years.
    Al Ammary F; Yu Y; Ferzola A; Motter JD; Massie AB; Yu S; Thomas AG; Crews DC; Segev DL; Muzaale AD; Henderson ML
    Am J Transplant; 2020 Dec; 20(12):3590-3598. PubMed ID: 32524764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.
    Muzaale AD; Massie AB; Anjum S; Liao C; Garg AX; Lentine KL; Segev DL
    Am J Transplant; 2016 Dec; 16(12):3532-3539. PubMed ID: 27172445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of excess weight on kidney donation: Long-term consequences of donor nephrectomy in obese donors.
    Serrano OK; Sengupta B; Bangdiwala A; Vock DM; Dunn TB; Finger EB; Pruett TL; Matas AJ; Kandaswamy R
    Surgery; 2018 Nov; 164(5):1071-1076. PubMed ID: 30149934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of end-stage renal disease following live kidney donation.
    Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
    JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial variation in medical outcomes among living kidney donors.
    Lentine KL; Schnitzler MA; Xiao H; Saab G; Salvalaggio PR; Axelrod D; Davis CL; Abbott KC; Brennan DC
    N Engl J Med; 2010 Aug; 363(8):724-32. PubMed ID: 20818874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.
    Vock DM; Helgeson ES; Mullan AF; Issa NS; Sanka S; Saiki AC; Mathson K; Chamberlain AM; Rule AD; Matas AJ
    BMC Nephrol; 2023 May; 24(1):121. PubMed ID: 37127560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Non-End-Stage Renal Disease Risks After Living Kidney Donation.
    Matas AJ; Hays RE; Ibrahim HN
    Am J Transplant; 2017 Apr; 17(4):893-900. PubMed ID: 27529688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative mortality and long-term survival following live kidney donation.
    Segev DL; Muzaale AD; Caffo BS; Mehta SH; Singer AL; Taranto SE; McBride MA; Montgomery RA
    JAMA; 2010 Mar; 303(10):959-66. PubMed ID: 20215610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of living kidney donors: a single centre experience of 29 years.
    Chu KH; Poon CK; Lam CM; Cheuk A; Yim KF; Lee W; Tang HL; Chan HW; Fung KS; Tong KL
    Nephrology (Carlton); 2012 Jan; 17(1):85-8. PubMed ID: 21919999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes and timing of end-stage renal disease after living kidney donation.
    Matas AJ; Berglund DM; Vock DM; Ibrahim HN
    Am J Transplant; 2018 May; 18(5):1140-1150. PubMed ID: 29369517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.
    Holscher CM; Ishaque T; Garonzik Wang JM; Haugen CE; DiBrito SR; Jackson KR; Muzaale AD; Massie AB; Al Ammary F; Ottman SE; Henderson ML; Segev DL
    Am J Transplant; 2018 Nov; 18(11):2804-2810. PubMed ID: 30086198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Use of the Expanded Criteria for Living Kidney Donation and Good Outcomes of Living Kidney Donors in Korea.
    Lim HJ; Jambaldorj E; Lee Y; Kang SS; Koo TY; Ahn C; Yang J
    Transplant Proc; 2016 Sep; 48(7):2407-2411. PubMed ID: 27742310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Mortality Risks Among Living Kidney Donors in Korea.
    Kim Y; Yu MY; Yoo KD; Jeong CW; Kim HH; Min SI; Ha J; Choi Y; Ko AR; Yun JM; Park SM; Yang SH; Kim DK; Oh KH; Joo KW; Ahn C; Kim YS; Lee H
    Am J Kidney Dis; 2020 Jun; 75(6):919-925. PubMed ID: 31866225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of kidney donors.
    Morgan BR; Ibrahim HN
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):605-9. PubMed ID: 21946164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity increases the risk of end-stage renal disease among living kidney donors.
    Locke JE; Reed RD; Massie A; MacLennan PA; Sawinski D; Kumar V; Mehta S; Mannon RB; Gaston R; Lewis CE; Segev DL
    Kidney Int; 2017 Mar; 91(3):699-703. PubMed ID: 28041626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks and outcomes of living donation.
    Lentine KL; Patel A
    Adv Chronic Kidney Dis; 2012 Jul; 19(4):220-8. PubMed ID: 22732041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.
    Purnell TS; Luo X; Cooper LA; Massie AB; Kucirka LM; Henderson ML; Gordon EJ; Crews DC; Boulware LE; Segev DL
    JAMA; 2018 Jan; 319(1):49-61. PubMed ID: 29297077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donation - any news on the donor?
    Haugen AJ; Mjøen G
    Curr Opin Organ Transplant; 2021 Feb; 26(1):85-90. PubMed ID: 33278148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.